Comparative Analysis of the Efficacy and Safety of Nafamostat Mesylate and Unfractionated Heparin for Anticoagulation during Extracorporeal Membrane Oxygenation

The requested reference [dad7e44da6af212dea959801e6b64b5cc6980c2f] no longer exists in our database. It has been replaced by the current reference: [4262e9377fe36e531703a7bc975649e1c1359b9b]

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: c510b29382ee5a5e5a47b696cc68e04745835175
First added on: Oct 10, 2026